US Broker Ratings

Novavax, Inc. (NVAX) Growth Potential: Analyst Ratings Highlight a 37.70% Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has captured the attention of both investors and industry analysts with its innovative approach to vaccine development. With a..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Unpacking the 41.80% Potential Upside

For investors eyeing the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents a compelling opportunity, particularly with analysts projecting a potential upside of 41.80%. This Bothell, Washington-based company specializes in..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector

Investors with an appetite for growth in the biotechnology sector may want to take a closer look at MiMedx Group, Inc. (NASDAQ: MDXG), a company that stands out with an..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring 147% Upside in Biotech Innovation

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, has captured investor attention with a remarkable potential upside of 147.22%. Specializing in RNA medicine, Wave Life Sciences leverages its..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a Potential 31.80% Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the medical devices industry, is currently capturing the attention of savvy investors. With a notable potential upside of 31.80%, as..

GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 104% Potential Upside Amidst Healthcare Innovations

GRAIL, Inc. (GRAL), a trailblazer in the healthcare sector, has attracted investor attention with its promising diagnostics and research innovations. Headquartered in Menlo Park, California, GRAIL is at the forefront..

NeoGenomics, Inc. (NEO) Stock Analysis: A 47% Upside Potential in the Healthcare Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO) stands as a prominent player in the healthcare diagnostics and research industry, with its specialized focus on cancer-related testing. Based in Fort Myers, Florida, NeoGenomics operates..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Unpacking a 52.78% Potential Upside

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is gaining attention in the healthcare sector, showcasing a promising potential upside of 52.78%, according to average analyst target prices. Specializing in diversified home..

U.S. Physical Therapy, Inc. (USPH)

⚠️ No article content returned.

..

Artivion, Inc. (AORT) Stock Analysis: Exploring a Promising 37.55% Potential Upside with Strong Buy Ratings

Investors eyeing the healthcare sector should take a closer look at Artivion, Inc. (AORT), a prominent player in the medical devices industry. With a market capitalization of $1.79 billion, Artivion..

Structure Therapeutics Inc. (GPCR): Analyst Consensus Points to a 60% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) has captured the attention of investors in the biotechnology sector, primarily due to its innovative approach to addressing chronic diseases with unmet medical needs. The..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 17.73% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) is emerging as an intriguing opportunity for investors within the healthcare sector, particularly those focused on medical care facilities. With a market capitalization of..

Biohaven Ltd. (BHVN) Stock Analysis: Navigating a Potential 80% Upside in the Biotechnology Sector

Biohaven Ltd. (NYSE: BHVN) stands as a compelling figure in the biotechnology landscape with a staggering 80.81% potential upside, according to the latest analyst ratings. Specializing in developing therapies for..

Arrowhead Pharmaceuticals, Inc. (ARWR): An Investor Outlook on Its 28.86% Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is capturing investor attention with its substantial growth potential. With a market capitalization of $8.84 billion and a..

Disc Medicine, Inc. (IRON) Stock Analysis: A High-Risk, High-Reward Play with 61.59% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector, capturing the attention of investors with its impressive market cap of $2.42 billion and a potential upside of..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 36% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands as a noteworthy contender in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.86 billion, this Massachusetts-based company..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Strong Buy Ratings Signal a 57% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a portfolio targeting some of the most challenging neurodegenerative and lysosomal storage diseases. Based in South San Francisco,..

Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with a significant potential upside of 37.95%. Headquartered in..

Evotec SE (EVO) Investor Outlook: Exploring a 66% Upside Potential in the Drug Discovery Sector

Evotec SE (EVO), a German-based leader in drug discovery and development, is capturing the attention of investors with its potential upside of 66.21% based on current analyst price targets. As..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 206.86% Potential Upside in the Healthcare Sector

Evolent Health, Inc. (NYSE: EVH) stands at a crossroads of opportunity and challenge, making it a compelling consideration for investors focused on the healthcare sector. With its current market cap..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds